×
GeneDx Holdings Total Assets 2020-2024 | WGS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GeneDx Holdings total assets from 2020 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
GeneDx Holdings Total Assets 2020-2024 | WGS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GeneDx Holdings total assets from 2020 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.8B
Avantor (AVTR)
$12B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B